Patients with fibromyalgia who used cannabis-based medicinal products demonstrated modest, medium-term improvements in pain, ...

Dear Doctors: I had muscle pain and exhaustion for two years, and no one could figure out what was wrong. A rheumatologist recently diagnosed me with fibromyalgia. I would appreciate any information ...

The study consists of an open-label AXS-14 treatment period followed by a randomised, double-blind treatment period.

Many people with fibromyalgia describe the chronic condition as a "bad case of the flu that never goes away," because they have widespread pain, wake up with stiff muscles and experience brain fog, ...

An unlikely, decades-old drug is gaining traction as a promising off-label treatment for fibromyalgia, driven by a handful of studies and a growing number of anecdotal reports. Low-dose naltrexone ...

SOLON, Ohio--(BUSINESS WIRE)--Pioneering the frontier of super-pulsed laser technology, Multi Radiance Medical highlights the impact of FibroLux Therapeutic Laser, one of the first and only ...

Fibromyalgia is a condition that can cause various symptoms involving pain and fatigue. A rheumatologist may treat this condition alongside a full medical team. Members of the treatment team may ...

AXS-14 (esreboxetine) is a highly selective and potent norepinephrine reuptake inhibitor being developed for the management of fibromyalgia. Esreboxetine is the SS-enantiomer of racemic reboxetine.

Please provide your email address to receive an email when new articles are posted on . For millions suffering from fibromyalgia, the relentless cycle of chronic pain, fatigue and inflammation can ...

PITTSBURGH--(BUSINESS WIRE)--Swing Therapeutics announced that Stanza, its digital therapeutic for treatment of fibromyalgia symptoms, has received a positive coverage decision from Highmark Health.

If you’re living with migraine and fibromyalgia, you may wonder what is going on in your body that could be causing these painful conditions — and whether there’s a connection between the two. In fact ...